Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: Implications for control of high blood pressure

European Heart Journal

Volumn 32, Issue 11, 2011, Pages 1424-1431

  Redon, Josep ^a   Olsen, Michael H ^b   Cooper, Richard S ^c   Zurriaga, Oscar ^d,e   Martinez Beneito, Miguel A ^e   Laurent, Stephane ^f   Cifkova, Renata ^g   Coca, Antonio ^h   Mancia, Guiseppe ⁱ  

^a UNIVERSITY OF VALENCIA   (Spain)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

^d Epidemiology Department   (Spain)

^e Centro Superior de Investigacion en Salud Publica CSISP   (Spain)

^f PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^g INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^h UNIVERSITY OF BARCELONA   (Spain)

ⁱ SAN GERARDO HOSPITAL   (Italy)

Author keywords

Europe mortality; Hypertension control; Stroke mortality

Indexed keywords

ADULT; AGED; ARTICLE; ASIA; BAYES THEOREM; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; EUROPE; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; ISRAEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; STROKE; SYSTOLIC BLOOD PRESSURE; WORLD HEALTH ORGANIZATION;

AGE DISTRIBUTION; AGED; ASIA, CENTRAL; EUROPE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MORTALITY; PREVALENCE; RESIDENCE CHARACTERISTICS; STROKE;

EID: 79958143478     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr045     Document Type: Article

References (33)

1. World Health Organization. The atlas of heart disease and stroke. http://www. who.int/cardiovascular-diseases/resources/atlas/en/index.html.
2. Warlow C, Sudlow C, Dennis M, Wardlaw J, Sandercock P. Stroke. Lancet 2003; 362:1211-1224. (Pubitemid 37255350)
3. D'Agostino R,Wolf PA, Belanger A, KannelW. Stroke risk profile: adjustment for antihypertensive medication. The Framinghan Study. Stroke 1994;25:40-43.
4. Staessen JA, Kuznetsova T, Stolarz K. Hypertension prevalence and stroke mortality across populations. JAMA 2003;289:2420-2422. (Pubitemid 37430177)
5. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-1053.
6. Zhang H, Thijs L, Staessen JA. Blood pressure lowering for primary and secondary prevention of stroke. Hypertension 2006;48:187-195. (Pubitemid 44321393)
7. Kjeldsen SE, Julius S, Hedner T, Hansson L. Stroke is more common than myocardial infarction in hypertension: analysis based on 11 major randomized intervention trials. Blood Press 2001;10:190-192. (Pubitemid 33149897)
8. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003;289:2363-2369. (Pubitemid 37430168)
9. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, Poulter N, Primatesta P, Stegmayr B, Thamm M. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004;43:10-17. (Pubitemid 38031904)
10. Müller-Nordhorn J, Binting S, Roll S, Willich SN. An update on regional variation in cardiovascular mortality within Europe. Europ Heart J 2008;29:1316-1326. (Pubitemid 351768126)
11. Stamler J. Lectures on Preventive Cardiology. New York: Grune and Stratton; 1967.
12. Eurostat. Mortality Atlas in the European Union. Luxembourg: Office for Official Publications of European Communities; 2003.
13. Cornia GA, Paniccia R, eds The Mortality Crisis in Transitional Economies. Oxford: Oxford University Press, 2000.
14. Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol 2009; 8:345-354.
15. World Health Organization. The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva: World Health Organization, 2002.
16. Surveillance of Chronic Disease Risk Factors: Country-level Data and Comparable Estimates (SuRF reports 2). Geneva: World Health Organization, 2005.
17. Congdon P. Chapter 8 in Bayesian Statistical Modelling. New Jersey: John Wiley, 2001.
18. Tapia JA. On economic growth, business fluctuations, and health progress. Int J Epidemiol 2005;34:1226-1233.
19. Müller-Nordhorn J, Binting S, Roll S, Willich SN. An update on regional variation in cardiovascular mortality within Europe. Eur Heart J 2008;29: 1316-1326. (Pubitemid 351768126)
20. Andersen KK, Olsen TS, Dehlendorff C, Kammersgaard LP. Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors. Stroke 2009;40:2068-2072.
21. Carandang R, Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Kannel WB,Wolf PA. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA 2006;296:2939-2946. (Pubitemid 46023453)
22. Lloyd-Williams F, O'Flaherty M, Mwatsama M, Birt C, Ireland R, Capewell S. Estimating the cardiovascular mortality burden attributable to the European Common Agricultural Policy on dietary saturated fats. Bull World Health Organ 2008;86:535-541A.
23. MacMahon S. Blood pressure and the risk of cardiovascular disease. N Engl J Med 2000;342:50-52. (Pubitemid 30020661)
24. Lawes CM, Vander Hoorn S, Rodgers A; International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 2008;371: 1513-1518. (Pubitemid 351626187)
25. Redón J, Cea-Calvo L, Lozano JV, Martí-Canales JC, Llisterri JL, Aznar J, González-Esteban J; PREV-ICTUS Study. Differences in blood pressure control and stroke mortality across Spain: the Prevención de Riesgo de Ictus (PREV-ICTUS) study. Hypertension 2007;49:799-805. (Pubitemid 351664224)
26. Boshuizen HC, Lanti M, Menotti A, Moschandreas J, Tolonen H, Nissinen A, Nedeljkovic S, Kafatos A, Kromhout D. Effects of past and recent blood pressure and cholesterol level on coronary heart disease and stroke mortality, accounting for measurement error. Am J Epidemiol 2007;165:398-409.
27. Asplund K, Karvanen J, Giampaoli S, Jousilahti P, Niemelä M, Broda G, Cesana G, Dallongeville J, Ducimetriere P, Evans A, Ferrières J, Haas B, Jorgensen T, Tamosiunas A, Vanuzzo D, Wiklund PG, Yarnell J, Kuulasmaa K, Kulathinal S; MORGAM Project. Relative risks for stroke by age, sex, and population based on follow-up of 18 European populations in the MORGAM Project. Stroke 2009; 40:2319-2326.
28. Campbell NR, Brant R, Johansen H, Walker RL, Wielgosz A, Onysko J, Gao RN, Sambell C, Phillips S, McAlister FA; Canadian Hypertension Education Program Outcomes Research Task Force. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension 2009;53: 128-134.
29. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet 2002;360:1347-1360. (Pubitemid 35341298)
30. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004;22:11-19. (Pubitemid 38293521)
31. Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part 1: estimates of blood pressure levels. J Hypertens 2006;24:413-422. (Pubitemid 43261900)
32. Cooper RS. Using public health indicators to measure the success of hypertension control. Hypertension 2007;49:773-774. (Pubitemid 351664220)
33. Salway R, Wakefield J. Sources of bias in ecological studies of non-rare events. Environ Ecol Stat 2005;12:321-347. (Pubitemid 40974095)